Heme Oxygenase 1: Does It Have a Role in Renal Cytoprotection?

American Journal of Kidney Diseases

Volumn 51, Issue 4, 2008, Pages 678-690

  Courtney, Aisling E ^a   Maxwell, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

genetic polymorphism; Heme oxygenase; renal injury

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; GUANOSINE; HEME OXYGENASE 1; IRON; THYMINE;

ADULT; ARTICLE; CASE REPORT; CELL PROTECTION; GENETIC POLYMORPHISM; HUMAN; KIDNEY INJURY; MALE; MOLECULAR GENETICS; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN EXPRESSION; TANDEM REPEAT;

ANIMALS; CYTOPROTECTION; HEME OXYGENASE-1; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION;

EID: 40849100577     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.11.033     Document Type: Article

References (129)

1. Sikorski E.M., Hock T., Hill-Kapturczak N., and Agarwal A. The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury. Am J Physiol Renal Physiol 286 (2004) F425-F441
2. Exner M., Minar E., Wagner O., and Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37 (2004) 1097-1104
3. Tenhunen R., Marver H.S., and Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A 61 (1968) 748-755
4. Maines M.D. The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37 (1997) 517-554
5. Hayashi S., Omata Y., Sakamoto H., et al. Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336 (2004) 241-250
6. Kutty R.K., Kutty G., Rodriguez I.R., Chader G.J., and Wiggert B. Chromosomal localization of the human heme oxygenase genes: Heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme oxygenase-2 (HMOX2) maps to chromosome 16p13.3. Genomics 20 (1994) 513-516
7. Platt J.L., and Nath K.A. Heme oxygenase: Protective gene or Trojan horse. Nat Med 4 (1998) 1364-1365
8. Alam J., and Cook J.L. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am J Respir Cell Mol Biol 36 (2007) 166-174
9. Hock T.D., Liby K., Wright M.M., et al. JunB and JunD regulate human heme oxygenase-1 gene expression in renal epithelial cells. J Biol Chem 282 (2007) 6875-6886
10. Rich A., Nordheim A., and Wang A.H. The chemistry and biology of left-handed Z-DNA. Annu Rev Biochem 53 (1984) 791-846
11. Naylor L.H., and Clark E.M. d(TG)n.d(CA)n sequences upstream of the rat prolactin gene form Z-DNA and inhibit gene transcription. Nucleic Acids Res 18 (1990) 1595-1601
12. Yamada N., Yamaya M., Okinaga S., et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66 (2000) 187-195
13. Chen Y.H., Lin S.J., Lin M.W., et al. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 111 (2002) 1-8
14. Hirai H., Kubo H., Yamaya M., et al. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 102 (2003) 1619-1621
15. Woo J., Iyer S., Cornejo M.C., et al. Stress protein-induced immunosuppression: Inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol 6 (1998) 84-93
16. Kitamuro T., Takahashi K., Ogawa K., et al. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278 (2003) 9125-9133
17. Lee P.J., Jiang B.H., Chin B.Y., et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272 (1997) 5375-5381
18. Motterlini R., Foresti R., Intaglietta M., and Winslow R.M. NO-mediated activation of heme oxygenase: Endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 270 (1996) H107-H114
19. Takahashi S., Takahashi Y., Yoshimi T., and Miura T. Oxygen tension regulates heme oxygenase-1 gene expression in mammalian cell lines. Cell Biochem Funct 16 (1998) 183-193
20. Yang Z.Z., and Zou A.P. Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells. Am J Physiol Renal Physiol 281 (2001) F900-F908
21. Kacimi R., Chentoufi J., Honbo N., Long C.S., and Karliner J.S. Hypoxia differentially regulates stress proteins in cultured cardiomyocytes: Role of the p38 stress-activated kinase signaling cascade, and relation to cytoprotection. Cardiovasc Res 46 (2000) 139-150
22. Maruhashi K., Kasahara Y., Ohta K., et al. Paradoxical enhancement of oxidative cell injury by overexpression of heme oxygenase-1 in an anchorage-dependent cell ECV304. J Cell Biochem 93 (2004) 552-562
23. Nath K.A., Balla G., Vercellotti G.M., et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90 (1992) 267-270
24. Ryter S.W., and Tyrrell R.M. The heme synthesis and degradation pathways: Role in oxidant sensitivity. Heme oxygenase has both pro- and antioxidant properties. Free Radic Biol Med 28 (2000) 289-309
25. Nath K.A., Vercellotti G.M., Grande J.P., et al. Heme protein-induced chronic renal inflammation: Suppressive effect of induced heme oxygenase-1. Kidney Int 59 (2001) 106-117
26. Inguaggiato P., Gonzalez-Michaca L., Croatt A.J., Haggard J.J., Alam J., and Nath K.A. Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis. Kidney Int 60 (2001) 2181-2191
27. Otterbein L.E., Zuckerbraun B.S., Haga M., et al. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9 (2003) 183-190
28. Gunther L., Berberat P.O., Haga M., et al. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 51 (2002) 994-999
29. Stevenson T.H., Gutierrez A.F., Alderton W.K., Lian L., and Scrutton N.S. Kinetics of CO binding to the haem domain of murine inducible nitric oxide synthase: Differential effects of haem domain ligands. Biochem J 358 (2001) 201-208
30. Otterbein L.E., Bach F.H., Alam J., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 (2000) 422-428
31. Pae H.O., Oh G.S., Choi B.M., et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol 172 (2004) 4744-4751
32. Brouard S., Otterbein L.E., Anrather J., et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 192 (2000) 1015-1026
33. Peyton K.J., Reyna S.V., Chapman G.B., et al. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood 99 (2002) 4443-4448
34. Song R., Mahidhara R.S., Zhou Z., et al. Carbon monoxide inhibits T lymphocyte proliferation via caspase-dependent pathway. J Immunol 172 (2004) 1220-1226
35. Thorup C., Jones C.L., Gross S.S., Moore L.C., and Goligorsky M.S. Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277 (1999) F882-F889
36. Nakagami T., Toyomura K., Kinoshita T., and Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: Anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1158 (1993) 189-193
37. Juckett M.B., Balla J., Balla G., Jessurun J., Jacob H.S., and Vercellotti G.M. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147 (1995) 782-789
38. Willis D., Moore A.R., Frederick R., and Willoughby D.A. Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 2 (1996) 87-90
39. Yachie A., Niida Y., Wada T., et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103 (1999) 129-135
40. White K.A., and Marletta M.A. Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31 (1992) 6627-6631
41. Lee H.T., Xu H., Ota-Setlik A., and Emala C.W. Oxidant preconditioning protects human proximal tubular cells against lethal oxidant injury via p38 MAPK and heme oxygenase-1. Am J Nephrol 23 (2003) 324-333
42. Vachharajani T.J., Work J., Issekutz A.C., and Granger D.N. Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol 278 (2000) H1613-H1617
43. Daly C., and Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 10 (2003) 247-257
44. Pittock S.T., Norby S.M., Grande J.P., et al. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int 68 (2005) 611-622
45. Gonzalez-Michaca L., Farrugia G., Croatt A.J., Alam J., and Nath K.A. Heme: A determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 286 (2004) F370-F377
46. McDaid J., Yamashita K., Chora A., et al. Heme oxygenase-1 modulates the allo-immune response by promoting activation-induced cell death of T cells. FASEB J 19 (2005) 458-460
47. Chauveau C., Remy S., Royer P.J., et al. Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression. Blood 106 (2005) 1694-1702
48. Kawamura K., Ishikawa K., Wada Y., et al. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25 (2005) 155-160
49. Nath K.A., Grande J.P., Croatt A.J., Likely S., Hebbel R.P., and Enright H. Intracellular targets in heme protein-induced renal injury. Kidney Int 53 (1998) 100-111
50. Bunn H.F., and Jandl J.H. The renal handling of hemoglobin. II. Catabolism. J Exp Med 129 (1969) 925-934
51. Nath K.A., Haggard J.J., Croatt A.J., Grande J.P., Poss K.D., and Alam J. The indispensability of heme oxygenase-1 in protecting against acute heme protein-induced toxicity in vivo. Am J Pathol 156 (2000) 1527-1535
52. Bissell D.M., and Hammaker L.E. Cytochrome P-450 heme and the regulation of hepatic heme oxygenase activity. Arch Biochem Biophys 176 (1976) 91-102
53. Shimizu H., Takahashi T., Suzuki T., et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 28 (2000) 809-817
54. Grace P.A. Ischaemia-reperfusion injury. Br J Surg 81 (1994) 637-647
55. Yoneya R., Nagashima Y., Sakaki K., et al. Hemolysate pretreatment ameliorates ischemic acute renal injury in rats. Nephron 92 (2002) 407-413
56. Toda N., Takahashi T., Mizobuchi S., et al. Tin chloride pretreatment prevents renal injury in rats with ischemic acute renal failure. Crit Care Med 30 (2002) 1512-1522
57. Neto J.S., Nakao A., Kimizuka K., et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 287 (2004) F979-F989
58. Nakao A., Neto J.S., Kanno S., et al. Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5 (2005) 282-291
59. Sung F.L., Zhu T.Y., Au-Yeung K.K., Siow Y.L., and Karmin O. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 62 (2002) 1160-1170
60. Cao C.C., Ding X.Q., Ou Z.L., et al. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65 (2004) 834-845
61. Furuichi K., Wada T., Iwata Y., et al. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol 14 (2003) 1066-1071
62. Furuichi K., Wada T., Iwata Y., et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol 14 (2003) 2503-2515
63. Mosley K., Wembridge D.E., Cattell V., and Cook H.T. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease. Kidney Int 53 (1998) 672-678
64. Datta P.K., and Lianos E.A. Nitric oxide induces heme oxygenase-1 gene expression in mesangial cells. Kidney Int 55 (1999) 1734-1739
65. Vogt B.A., Shanley T.P., Croatt A., Alam J., Johnson K.J., and Nath K.A. Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 98 (1996) 2139-2145
66. Maser R.L., Vassmer D., Magenheimer B.S., and Calvet J.P. Oxidant stress and reduced antioxidant enzyme protection in polycystic kidney disease. J Am Soc Nephrol 13 (2002) 991-999
67. Kawada N., Moriyama T., Ando A., et al. Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int 56 (1999) 1004-1013
68. Diamond J.R., Kees-Folts D., Ding G., Frye J.E., and Restrepo N.C. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am J Physiol 266 (1994) F926-F933
69. Rosenberg M.E., Smith L.J., Correa-Rotter R., and Hostetter T.H. The paradox of the renin-angiotensin system in chronic renal disease. Kidney Int 45 (1994) 403-410
70. Haugen E.N., Croatt A.J., and Nath K.A. Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58 (2000) 144-152
71. Ruiz-Ortega M., Bustos C., Hernandez-Presa M.A., Lorenzo O., Plaza J.J., and Egido J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 161 (1998) 430-439
72. Wolf G., Jocks T., Zahner G., Panzer U., and Stahl R.A. Existence of a regulatory loop between MCP-1 and TGF-beta in glomerular immune injury. Am J Physiol Renal Physiol 283 (2002) F1075-F1084
73. Hill-Kapturczak N., Truong L., Thamilselvan V., Visner G.A., Nick H.S., and Agarwal A. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-beta in human renal epithelial cells. J Biol Chem 275 (2000) 40904-40909
74. Ohta K., Yachie A., Fujimoto K., et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis 35 (2000) 863-870
75. Morimoto K., Ohta K., Yachie A., et al. Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney Int 60 (2001) 1858-1866
76. Courtney A.E., McNamee P.T., Heggarty S., Middleton D., and Maxwell A.P. Association of functional heme oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy. Nephrol Dial Transplant 23 (2008) 608-611
77. Shoskes D.A., and Cecka J.M. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 66 (1998) 1697-1701
78. Daemen M.A., de Vries B., and Buurman W.A. Apoptosis and inflammation in renal reperfusion injury. Transplantation 73 (2002) 1693-1700
79. Halloran P.F., Homik J., Goes N., et al. The "injury response": A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29 (1997) 79-81
80. Laskowski I., Pratschke J., Wilhelm M.J., Gasser M., and Tilney N.L. Molecular and cellular events associated with ischemia/reperfusion injury. Ann Transplant 5 (2000) 29-35
81. Lu C.Y., Penfield J.G., Kielar M.L., Vazquez M.A., and Jeyarajah D.R. Hypothesis: Is renal allograft rejection initiated by the response to injury sustained during the transplant process?. Kidney Int 55 (1999) 2157-2168
82. Goes N., Urmson J., Ramassar V., and Halloran P.F. Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 59 (1995) 565-572
83. Raftery M.J., Seron D., Koffman G., Hartley B., Janossy G., and Cameron J.S. The relevance of induced class II HLA antigens and macrophage infiltration in early renal allograft biopsies. Transplantation 48 (1989) 238-243
84. Austyn J.M., and Larsen C.P. Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation 49 (1990) 1-7
85. Robertson H., Ali S., McDonnell B.J., Burt A.D., and Kirby J.A. Chronic renal allograft dysfunction: The role of T cell-mediated tubular epithelial to mesenchymal cell transition. J Am Soc Nephrol 15 (2004) 390-397
86. Djamali A., Reese S., Yracheta J., Oberley T., Hullett D., and Becker B. Epithelial-to-mesenchymal transition and oxidative stress in chronic allograft nephropathy. Am J Transplant 5 (2005) 500-509
87. Matsuno T., Sasaki H., Ishido N., et al. Apoptosis in human kidney allografts. Transplant Proc 28 (1996) 1226-1227
88. Wagner M., Cadetg P., Ruf R., Mazzucchelli L., Ferrari P., and Redaelli C.A. Heme oxygenase-1 attenuates ischemia/reperfusion-induced apoptosis and improves survival in rat renal allografts. Kidney Int 63 (2003) 1564-1573
89. Martins P.N., Reuzel-Selke A., Jurisch A., et al. Induction of carbon monoxide in the donor reduces graft immunogenicity and chronic graft deterioration. Transplant Proc 37 (2005) 379-381
90. Tullius S.G., Nieminen-Kelha M., Bachmann U., et al. Induction of heme-oxygenase-1 prevents ischemia/reperfusion injury and improves long-term graft outcome in rat renal allografts. Transplant Proc 33 (2001) 1286-1287
91. Tullius S.G., Nieminen-Kelha M., Reutzel-Selke A., et al. Improvement of long-term function in renal allografts from 'marginal donors' following the induction of heme-oxygenase-1. Transplant Proc 33 (2001) 1160-1161
92. Blydt-Hansen T.D., Katori M., Lassman C., et al. Gene transfer-induced local heme oxygenase-1 overexpression protects rat kidney transplants from ischemia/reperfusion injury. J Am Soc Nephrol 14 (2003) 745-754
93. Cuturi M.C., Christoph F., Woo J., et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: Analysis of its mechanism of action. Mol Med 5 (1999) 820-832
94. Neto J.S., Nakao A., Toyokawa H., et al. Low-dose carbon monoxide inhalation prevents development of chronic allograft nephropathy. Am J Physiol Renal Physiol 290 (2006) F324-F334
95. Bedard E.L., Jiang J., Parry N., et al. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection. Transpl Int 18 (2005) 341-349
96. Sato K., Balla J., Otterbein L., et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166 (2001) 4185-4194
97. Katori M., Buelow R., Ke B., et al. Heme oxygenase-1 overexpression protects rat hearts from cold ischemia/reperfusion injury via an antiapoptotic pathway. Transplantation 73 (2002) 287-292
98. Akamatsu Y., Haga M., Tyagi S., et al. Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 18 (2004) 771-772
99. Hancock W.W., Buelow R., Sayegh M.H., and Turka L.A. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 4 (1998) 1392-1396
100. Tsui T.Y., Wu X., Lau C.K., et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 107 (2003) 2623-2629
101. Braudeau C., Bouchet D., Tesson L., et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 11 (2004) 701-710
102. Araujo J.A., Meng L., Tward A.D., et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 171 (2003) 1572-1580
103. Kato H., Amersi F., Buelow R., et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 1 (2001) 121-128
104. Amersi F., Buelow R., Kato H., et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104 (1999) 1631-1639
105. Wang X.H., Wang K., Zhang F., et al. Heme oxygenase-1 alleviates ischemia/reperfusion injury in aged liver. World J Gastroenterol 11 (2005) 690-694
106. Squiers E.C., Bruch D., Buelow R., and Tice D.G. Pretreatment of small bowel isograft donors with cobalt-protoporphyrin decreases preservation injury. Transplant Proc 31 (1999) 585-586
107. Song R., Kubo M., Morse D., et al. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 163 (2003) 231-242
108. Bonnell M.R., Visner G.A., Zander D.S., et al. Heme-oxygenase-1 expression correlates with severity of acute cellular rejection in lung transplantation. J Am Coll Surg 198 (2004) 945-952
109. Pileggi A., Molano R.D., Berney T., et al. Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50 (2001) 1983-1991
110. Nijboer W.N., Schuurs T.A., van der Hoeven J.A., et al. Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 78 (2004) 978-986
111. Lemos F.B., Ijzermans J.N., Zondervan P.E., et al. Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol 14 (2003) 3278-3287
112. Avihingsanon Y., Ma N., Pavlakis M., et al. On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol 16 (2005) 1542-1548
113. Avihingsanon Y., Ma N., Csizmadia E., et al. Expression of protective genes in human renal allografts: A regulatory response to injury associated with graft rejection. Transplantation 73 (2002) 1079-1085
114. Serinsoz E., Bock O., Kirsch T., et al. Compartment-specific quantitative gene expression analysis after laser microdissection from archival renal allograft biopsies. Clin Nephrol 63 (2005) 193-201
115. Exner M., Bohmig G.A., Schillinger M., et al. Donor heme oxygenase-1 genotype is associated with renal allograft function. Transplantation 77 (2004) 538-542
116. Baan C., Peeters A., Lemos F., et al. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 4 (2004) 811-818
117. Courtney A.E., McNamee P.T., Middleton D., Heggarty S., Patterson C.C., and Maxwell A.P. Association of functional heme oxygenase-1 gene promoter polymorphism with renal transplantation outcomes. Am J Transplant 7 (2007) 908-913
118. Holweg C.T., Balk A.H., Uitterlinden A.G., et al. Functional heme oxygenase-1 promoter polymorphism in relation to heart failure and cardiac transplantation. J Heart Lung Transplant 24 (2005) 493-497
119. Ullrich R., Exner M., Schillinger M., et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter and cardiac allograft vasculopathy. J Heart Lung Transplant 24 (2005) 1600-1605
120. Kaneda H., Ohno M., Taguchi J., et al. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 22 (2002) 1680-1685
121. Endler G., Exner M., Schillinger M., et al. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with increased bilirubin and HDL levels but not with coronary artery disease. Thromb Haemost 91 (2004) 155-161
122. Lin C.C., Yang W.C., Lin S.J., et al. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69 (2006) 165-172
123. Colhoun H.M., McKeigue P.M., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 (2003) 865-872
124. Schnuelle P., Yard B.A., Braun C., et al. Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 4 (2004) 419-426
125. van der Woude F.J., Schnuelle P., and Yard B.A. Preconditioning strategies to limit graft immunogenicity and cold ischemic organ injury. J Invest Med 52 (2004) 323-329
126. McNally S.J., Harrison E.M., Ross J.A., Garden O.J., and Wigmore S.J. Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury. Transplantation 81 (2006) 623-626
127. Shoskes D., Lapierre C., Cruz-Correa M., et al. Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation 80 (2005) 1556-1559
128. Harrison E.M., McNally S.J., Devey L., Garden O.J., Ross J.A., and Wigmore S.J. Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J 273 (2006) 2345-2356
129. Bhaskaran M., Radhakrishnan N., Patni H., Singh P., Chaudhary A.N., and Singhal P.C. Dialysis membrane-induced oxidative stress: Role of heme oxygenase-1. Nephron Exp Nephrol 105 (2007) e24-e32